Lopinavir-Ritonavir for the Treatment and Prevention of COVID-19: A Review of Clinical Effectiveness Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: August 19, 2020 Also available in Français
CADTH Emerging Health Technology for COVID-19: Favipiravir Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: August 17, 2020 Also available in Français
Re-opening, Operation, and Monitoring of Schools Product: — Evidence Synthesis Network School Protocols Schools & Learning esnetwork.ca Last Updated: August 17, 2020
Dexamethasone in Patients Hospitalized for COVID-19 Product: — Science Table Drug Interventions Treatments covid19-sciencetable.ca Last Updated: August 12, 2020
Dexamethasone in the Treatment of Hospitalized Patients With COVID-19: A Critical Appraisal of the RECOVERY Study Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: July 24, 2020 Also available in Français
COVID-19: Interim Recommendations for Public Health Management of Cases and Contacts in the Community Product: — Institut national de santé publique du Québec Public Health Policy Regulation & Policy Testing & Tracing Tracing www.inspq.qc.ca Last Updated: July 17, 2020 Also available in Français
Gabapentin, Phenobarbital, Diazepam, and Lorazepam for the Treatment of Alcohol Withdrawal: Clinical Effectiveness and Guidelines Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: June 23, 2020 Also available in Français
Methoxyflurane for Acute Pain: Clinical Effectiveness Product: — Canadian Agency for Drugs and Technologies in Health Drug Interventions Treatments covid.cadth.ca Last Updated: May 25, 2020 Also available in Français